Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 20 Jun 2029. The purpose of this notice of funding opportunity (NOFO) is to support implementation research on strategies to improve the uptake, implementation, sustainment, scale and/or spread of evidence-based prevention, treatment, and care interventions in communities in the U.S. significantly impacted by HI…
Opportunity overview
- Project name
- Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)
- Donor
- National Institutes of Health
Key details
- Opportunity start date
- Opportunity end date
- Project location(s)
- United States
Summary
Frequently asked questions
What is Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)?
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) is a published development and funding opportunity on Contexium. The donor or funder is National Institutes of Health. Project location(s): United States. Applications close on 20 Jun 2029. The purpose of this notice of funding opportunity (NOFO) is to support implementation research on strategies to improve the uptake, implementation, sustainment, scale and/or spread of evidence-based prevention, treatment, and care interventions in communities in the U.S. significantly impacted by HI…
Who is funding Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)?
Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) is funded by National Institutes of Health.
When is the deadline to apply for Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)?
The application deadline is 20 Jun 2029 00:00 (UTC).
Where will the Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional) project take place?
The project location(s) are: United States.
How can I apply for Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)?
Create a free Contexium account to view the full opportunity details and submit an application via the marketplace.